Literature DB >> 21948149

Prevalence of defaecatory disorders in morbidly obese patients before and after bariatric surgery.

Pierpaolo Sileri1, Luana Franceschilli, Federica Cadeddu, Elisabetta De Luca, Stefano D'Ugo, Valeria Tognoni, Ida Camperchioli, Domenico Benavoli, Nicola Di Lorenzo, Achille L Gaspari, Paolo Gentileschi.   

Abstract

BACKGROUND: The prevalence of obesity is increasing worldwide and has lately reached epidemic proportions in western countries. Several epidemiological studies have consistently shown that both overweight and obesity are important risk factors for the development of various functional defaecatory disorders (DDs), including faecal incontinence and constipation. However, data on their prevalence as well as effectiveness of bariatric surgery on their correction are scant. The primary objective of this study was to estimate the effect of morbid obesity on DDs in a cohort of patients listed for bariatric surgery. We also evaluated preliminary results of the effects of sleeve gastrectomy on these disorders. PATIENTS AND METHODS: A questionnaire-based study was proposed to morbidly obese patients having bariatric surgery. Data included demographics, past medical, surgical and obstetrics histories, as well as obesity related co-morbidities. Wexner Constipation Score (WCS) and the Faecal Incontinence Severity Index (FISI) questionnaires were used to evaluate constipation and incontinence. For the purpose of this study, we considered clinically relevant a WCS ≥5 and a FISI score ≥10. The same questionnaires were completed at 3 and 6 months follow-up after surgery.
RESULTS: A total of 139 patients accepted the study and 68 underwent sleeve gastrectomy and fully satisfied our inclusion criteria with a minimum follow-up of 6 months. Overall, mean body mass index (BMI) at listing was 47 ± 7 kg/m(2) (range 35-67 kg/m(2)). Mean WCS was 4.1 ± 4 (range 0-17), while mean FISI score (expressed as mean±standard deviation) was 9.5 ± 9 (range 0-38). Overall, 58.9% of the patients reported DDs according to the above-mentioned scores. Twenty-eight patients (20%) had WCS ≥5. Thirty-five patients (25%) had a FISI ≥10 while 19 patients (13.7%) reported combined abnormal scores. Overall, DDs were more evident with the increase of obesity grade: Mean BMI decreased significantly from 47 ± 7 to 36 ± 6 and to 29 ± 4 kg/m(2) respectively at 3 and 6 months after surgery (p < 0.0001). According to the BMI decrease, the mean WCS decreased from 3.7 ± 3 to 3.1 ± 4 and to 1.6 ± 3 respectively at 3 and 6 months (p = 0.02). Similarly, the FISI score decreased from 10 ± 8 to 3 ± 4 and to 1 ± 2 respectively at 3 and 6 months (p = 0.0001).
CONCLUSIONS: Defaecatory disorders are common in morbidly obese patients. The risk of DDs increases with BMI. Bariatric surgery reduces DDs, mainly faecal incontinence, and these findings correlated with BMI reduction.

Entities:  

Mesh:

Year:  2011        PMID: 21948149     DOI: 10.1007/s11605-011-1705-5

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  12 in total

1.  Obesity and urinary incontinence in women: is the black box becoming grayer?

Authors:  Wael Agur; Diaa E E Rizk
Journal:  Int Urogynecol J       Date:  2010-10-06       Impact factor: 2.894

2.  Incontinence: an underappreciated problem in obesity and bariatric surgery.

Authors:  Adil E Bharucha
Journal:  Dig Dis Sci       Date:  2010-09       Impact factor: 3.199

3.  Obesity and chronic gastrointestinal tract symptoms in young adults: a birth cohort study.

Authors:  Nicholas J Talley; Stuart Howell; Richie Poulton
Journal:  Am J Gastroenterol       Date:  2004-09       Impact factor: 10.864

4.  Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study.

Authors:  Silvia Delgado-Aros; G Richard Locke; Michael Camilleri; Nicholas J Talley; Sara Fett; Alan R Zinsmeister; L Joseph Melton
Journal:  Am J Gastroenterol       Date:  2004-09       Impact factor: 10.864

5.  High body mass alters colonic sensory-motor function and transit in humans.

Authors:  Silvia Delgado-Aros; Michael Camilleri; Montse Andreu Garcia; Duane Burton; Irene Busciglio
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-07-10       Impact factor: 4.052

6.  Fecal incontinence in obese women with urinary incontinence: prevalence and role of dietary fiber intake.

Authors:  Alayne D Markland; Holly E Richter; Kathryn L Burgio; Charlotte Bragg; Alexandra L Hernandez; Leslee L Subak
Journal:  Am J Obstet Gynecol       Date:  2009-01-10       Impact factor: 8.661

7.  Association of upper and lower gastrointestinal tract symptoms with body mass index in an Australian cohort.

Authors:  N J Talley; C Quan; M P Jones; M Horowitz
Journal:  Neurogastroenterol Motil       Date:  2004-08       Impact factor: 3.598

Review 8.  The obesity epidemic in the United States--gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis.

Authors:  Youfa Wang; May A Beydoun
Journal:  Epidemiol Rev       Date:  2007-05-17       Impact factor: 6.222

9.  Fecal incontinence among morbid obese women seeking for weight loss surgery: an underappreciated association with adverse impact on quality of life.

Authors:  Nir Wasserberg; Mark Haney; Patrizio Petrone; Peter Crookes; Jason Rosca; Manfred Ritter; Howard S Kaufman
Journal:  Int J Colorectal Dis       Date:  2008-01-29       Impact factor: 2.571

10.  Prevalence and degree of bother from pelvic floor disorders in obese women.

Authors:  Emily L Whitcomb; Emily S Lukacz; Jean M Lawrence; Charles W Nager; Karl M Luber
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-11-11
View more
  16 in total

1.  Percutaneous electrical neurostimulation of dermatome T6 for appetite reduction and weight loss in morbidly obese patients.

Authors:  Jaime Ruiz-Tovar; Inmaculada Oller; María Diez; Lorea Zubiaga; Antonio Arroyo; Rafael Calpena
Journal:  Obes Surg       Date:  2014-02       Impact factor: 4.129

Review 2.  Dietary Fibre Intake and Bowel Habits After Bariatric Surgery: a Structured Literature Review.

Authors:  C S Grosse; V C Cope
Journal:  Obes Surg       Date:  2019-07       Impact factor: 4.129

3.  Changes in bowel habits after laparoscopic sleeve gastrectomy.

Authors:  Petr Ostruszka; Petr Vávra; Lubomír Tulinský; Peter Ihnát
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2019-11-18       Impact factor: 1.195

4.  The effect of obesity on fecal incontinence symptom distress, quality of life, and diagnostic testing measures in women.

Authors:  David R Ellington; Michael R Polin; Jeff M Szychowski; Luqin Deng; Holly E Richter
Journal:  Int Urogynecol J       Date:  2013-05-04       Impact factor: 2.894

Review 5.  Management of functional constipation in children and adults.

Authors:  Mana H Vriesman; Ilan J N Koppen; Michael Camilleri; Carlo Di Lorenzo; Marc A Benninga
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-11-05       Impact factor: 46.802

6.  Conservative treatment for anal incontinence.

Authors:  Dan Carter
Journal:  Gastroenterol Rep (Oxf)       Date:  2014-03-18

7.  Matrix metalloproteinase-3 gene promoter polymorphisms: A potential risk factor for pelvic organ prolapse.

Authors:  Charalampos Karachalios; Panagiotis Bakas; Georgios Kaparos; Styliani Demeridou; Ilias Liapis; Charalampos Grigoriadis; Aggelos Liapis
Journal:  Biomed Rep       Date:  2016-08-03

8.  Changes in gastrointestinal symptoms and food tolerance 6 months following weight loss surgery: associations with dietary changes, weight loss and the surgical procedure.

Authors:  Anne Stine Kvehaugen; Per G Farup
Journal:  BMC Obes       Date:  2018-12-03

9.  Prevalence of functional gastrointestinal disorders according to Rome III criteria in Italian morbidly obese patients.

Authors:  Antonella Santonicola; Luigi Angrisani; Carolina Ciacci; Paola Iovino
Journal:  ScientificWorldJournal       Date:  2013-11-04

Review 10.  Diarrhea after bariatric procedures: Diagnosis and therapy.

Authors:  Yves M Borbély; Alice Osterwalder; Dino Kröll; Philipp C Nett; Roman A Inglin
Journal:  World J Gastroenterol       Date:  2017-07-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.